RECK overexpression decreases invasive potential in prostate cancer cells. (Q39453260)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22025325%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

RECK overexpression decreases invasive potential in prostate cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22025325%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22025325%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Anja Rabien

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22025325%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Bettina Ergün

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22025325%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Andreas Erbersdobler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22025325%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Carsten Stephan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22025325%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

24 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22025325%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22025325%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22025325%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22025325%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

948-954

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22025325%20AND%20SRC:MED&resulttype=core&format=json

Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) interacts with membrane type 1 matrix metalloproteinase and CD13/aminopeptidase N and modulates their endocytic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

Tgat oncoprotein functions as a inhibitor of RECK by association of the unique C-terminal region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

The tumor suppressor RECK interferes with HER-2/Neu dimerization and attenuates its oncogenic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

TIMP-2 upregulates RECK expression via dephosphorylation of paxillin tyrosine residues 31 and 118.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

MicroRNA expression and regulation in mouse uterus during embryo implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

miR-21 plays a pivotal role in gastric cancer pathogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

From pathogenesis to prevention of castration resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

RECK negatively regulates matrix metalloproteinase-9 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

Density- and serum-dependent regulation of the Reck tumor suppressor in mouse embryo fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

The ß1-integrin-dependent function of RECK in physiologic and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21498

21 January 2018

Identifiers

DOI

10.1002/PROS.21498

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22025325%20AND%20SRC:MED&resulttype=core&format=json

release_dq6hvh6dnbblvkd3cbahsvamei

15 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dq6hvh6dnbblvkd3cbahsvamei

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference